Sustainable Clinical Development of Adjuvant Chemotherapy for Colon Cancer
Sustainable Clinical Development of Adjuvant Chemotherapy for Colon Cancer
About this item
Full title
Author / Creator
Publisher
Japan: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Japan: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Numerous clinical studies in an adjuvant setting have been conducted and the combination therapy of 5‐fluorouracil and oxaliplatin has been established as the standard treatment for Stage III and as an option for high‐risk Stage II patients. Biologics such as bevacizumab and antiepidermal growth factor receptor antibodies have failed to show additi...
Alternative Titles
Full title
Sustainable Clinical Development of Adjuvant Chemotherapy for Colon Cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a70d4fea35e44e46839fa80ad5e9b377
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a70d4fea35e44e46839fa80ad5e9b377
Other Identifiers
ISSN
2475-0328
E-ISSN
2475-0328
DOI
10.1002/ags3.12503
